279 Shares in Waters Co. (NYSE:WAT) Bought by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB purchased a new stake in Waters Co. (NYSE:WAT) in the 3rd quarter, HoldingsChannel reports. The fund purchased 279 shares of the medical instruments supplier’s stock, valued at approximately $100,000.

Other institutional investors have also recently made changes to their positions in the company. Summit Trail Advisors LLC grew its stake in shares of Waters by 2.4% in the 3rd quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier’s stock valued at $431,000 after buying an additional 28 shares during the period. OneDigital Investment Advisors LLC boosted its holdings in Waters by 3.8% in the third quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock worth $306,000 after acquiring an additional 31 shares in the last quarter. Raymond James Trust N.A. grew its stake in Waters by 2.4% in the third quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier’s stock valued at $482,000 after acquiring an additional 32 shares during the period. Linscomb Wealth Inc. increased its holdings in shares of Waters by 0.4% during the second quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier’s stock valued at $2,275,000 after acquiring an additional 34 shares in the last quarter. Finally, Johnson Investment Counsel Inc. raised its position in shares of Waters by 3.2% during the second quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier’s stock worth $314,000 after purchasing an additional 34 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

WAT opened at $368.16 on Friday. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $397.02. The firm has a 50-day moving average of $367.05 and a 200 day moving average of $337.42. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. The firm has a market cap of $21.86 billion, a P/E ratio of 35.13, a PEG ratio of 6.92 and a beta of 1.01.

Waters (NYSE:WAT) last announced its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, beating the consensus estimate of $2.68 by $0.25. The business had revenue of $740.30 million during the quarter, compared to analyst estimates of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. Waters’s revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.84 earnings per share. On average, research analysts expect that Waters Co. will post 11.79 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Stifel Nicolaus lifted their price target on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Evercore ISI lifted their price objective on shares of Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. upped their target price on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Finally, Barclays boosted their price objective on Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, nine have issued a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $375.85.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.